24/7 Patient Assistance: 760-405-8205

David Bajor, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Education & Training

    dept_icon

    Case Western Reserve University School of Medicine

    Medical School

    dept_icon

    University of Pennsylvania Health System

    Residency

    dept_icon

    University of Pennsylvania Health System

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Hospital of the University of Pennsylvania

    Languages: English/Spanish

    (215) 662-4000

    3400 Spruce St

    Philadelphia, Pennsylvania 19104

    Read More
  • Publications & Memberships

    Dr. David Bajor has contributed to 3 publications.

    Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.

    Evans RA, Diamond MS, Rech AJ, Chao T, Richardson MW, Lin JH, Bajor DL, Byrne KT, Stanger BZ, Riley JL, Markosyan N, Winograd R, Vonderheide RH; JCI Insight. 2016-09-08.

    See more >>

    Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.

    Winograd, R.,Byrne, K. T.,Evans, R. A.,Odorizzi, P. M.,Meyer, A. R.,Bajor, D. L.,Clendenin, C.,Stanger, B. Z.,Furth, E. E.,Wherry, E. J.,Vonderheide, R. H.; Cancer Immunol Res. 2015 Feb 14.

    See more >>

    Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma.

    Bajor, D. L.,Xu, X.,Torigian, D. A.,Mick, R.,Garcia, L. R.,Richman, L. P.,Desmarais, C.,Nathanson, K. L.,Schuchter, L. M.,Kalos, M.,Vonderheide, R. H.; Cancer Immunol Res. 2014 Sep 26.

    See more >>